CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Continuous Glucose Monitor (CGM)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01586065
NCT01586065N/ACompleted
CompareCT.gov

Use of CGM in Adolescents With Poorly-controlled Type 1 Diabetes

Nemours Children's Clinic·interventional·Posted Apr 26, 2012·Updated Jun 28, 2023

In Brief

A clinical study evaluating Continuous Glucose Monitor (CGM) for Type 1 Diabetes. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to see if children and adolescents with poorly controlled type 1 diabetes will benefit from using a continuous glucose monitor (CGM), a device that can be used to check blood sugars.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.2 years ago

Interventions

Continuous Glucose Monitor (CGM)device

CGM during 24-hr CRC stay.